down arrow

Poly Medicure

  • Market Cap: Large Cap
  • Industry: Medical Equipment/Supplies/Accessories
  • ISIN: INE205C01021
  • NSEID: POLYMED
  • BSEID: 531768
INR
2,134.10
97.7 (4.8%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 54.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Poly Medicure Ltd stock-summary
stock-summary
Poly Medicure Ltd
Large Cap
Medical Equipment/Supplies/Accessories
Poly Medicure Limited was incorporated on 30th March 1995. The Company is a manufacturer/producer of Medical Devices. It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others.
Company Coordinates stock-summary
Company Details
Property No 232B 3rd Floor, Okhla Indl Estate Phase-III New Delhi New Delhi : 110020
stock-summary
Tel: 91-11-26321838/81/89/93
stock-summary
investorcare@polymedicure.com
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 50.65 Cr
Number of Shares
10.13 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
22-Aug-2024
10.13
50.65
5319148
5
Qualified Institutional Placement
08-Mar-2024
9.6
47.99
700
5
Issued under ESOP Scheme
14-Feb-2024
9.6
47.99
26375
5
Issued under ESOP Scheme
31-Jan-2024
9.6
47.99
26375
5
Issued under ESOP Scheme
06-Mar-2023
9.59
47.97
26250
5
Issued under ESOP Scheme
30-Jan-2023
9.6
47.99
52500
5
Issued under ESOP Scheme
04-Aug-2022
9.59
47.96
17750
5
Issued under ESOP Scheme
01-Nov-2021
9.59
47.95
19775
5
Issued under ESOP Scheme
18-Feb-2021
9.59
47.94
7633587
5
Issued to QIBs
18-Mar-2019
8.82
44.12
10050
5
ESOP
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 19 Schemes (7.35%)

FIIs

Held by 179 FIIs (11.86%)

Promoter with highest holding

Ezekiel Global Business Solutions Llp (12.2%)

Highest Public shareholder

Quant Mutual Fund - Quant Large Cap Fund (3.51%)

Individual Investors Holdings

10.14%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Devendra Raj Mehta
Chairman & Independent Directo
12.5 lacs
Jugal Kishore Baid
Non-Exec & Non-Independent Dir
11.25 lacs
Prakash Chand Surana
Non-Exec. & Independent Dir.
12.0 lacs
Himanshu Baid
Managing Director & CEO
10.72 cr
Rishi Baid
Joint Managing Director
10.43 cr
Shailendra Raj Mehta
Non-Exec. & Independent Dir.
12.25 lacs
Mukulika Baid
Non-Exec & Non-Independent Dir
11.25 lacs
Avinash Chandra
Company Sec. & Compli. Officer
0
Sandeep Bhargava
Non-Exec. & Independent Dir.
11.5 lacs
Alessandro Balboni
Non-Exec & Non-Independent Dir
0
Amit Khosla
Non-Exec. & Independent Dir.
12.0 lacs
Sonal Matto
Non-Exec. & Independent Dir.
11.0 lacs
Ambrish Mithal
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenues
0.81
0.14%
 
0.14
Other Operating Revenues
99.86
Other Operating Revenues
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
424 Cr
(Quarterly Results - Dec 2024)
Net Profit:
85 Cr
stock-summary
Industry

Medical Equipment/Supplies/Accessories

stock-summary
Market cap

INR 21,624 Cr (Large Cap)

stock-summary
P/E

65.00

stock-summary
Industry P/E

53

stock-summary
Dividend Yield

0.15%

stock-summary
Debt Equity

-0.42

stock-summary
Return on Equity

11.38%

stock-summary
Price to Book

7.96